Treatment of ischemic retinal injury by administration of various cytokines through vitreous cavity.

通过玻璃体腔施用各种细胞因子治疗缺血性视网膜损伤。

基本信息

  • 批准号:
    07557109
  • 负责人:
  • 金额:
    $ 11.26万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

Purpose :Phosphate-activated glutaminase (PAG) activity decreases markedly in the early period of ischemia. The decrease of the enzyme activity is reversible if the ischemic period is relatively short, but it ibecomes irreversible after 90 minutes of ischemia. The deterioration is a functional damage of the retinas caused by ischemia. We studied effects of growth factors and neurotrophic factors on protection of PAG in the ischemic and reperfused rat retinas.Methods :Before ischemia, 1mul of growth factors or neurotrofic factors (0.1 mug/mul for insulin-like growth factor-l (IGF-I) , insulin-like growth factor-II (IGF-II) , brain-derived neurotrophic factor (BDNF) , nerve growth factor (NGF) ; 1 mug/mul for basic fibroblast growth factor (bFGF)) were injected into the vitreous cavity of the left eyes of anesthetized Sprague Dawley rats. As a control, phosphate buffered saline was injected to the right eyes. To induce ischemia, we clamped left eyes for 90 minutes after bulbar conjunctival incision all around limbus. The rat retinas were homogenized with distillled water 1 day after reperfusion and used for PAG assay. Retinal ammonia concentration was also determined as a ischemic marker.Results :About 80% decrease of retinal PAG activity and 50% increase of retinal ammonia concentration were observed after 90 minutes of ischemia and 1 day of reperfusion as compared with unoperated normal eyes. IGF-II,BDNF and NGF had protective effects on the retinal PAG activity, whereas IGF-I,bFGF,stable bFGF were less effective. In addition, IGF-II and BDNF suppressed elevation of retinal ammonia concentration.Conclusions :BDNF,NGF and IGF-II have marked effect on the protection of PAG activity in the ischemic and reperfused rat retinas, whereas bFGF,which is very effective for the protection of ischemic cell death, shows moderate effect.
目的:缺血早期磷酸活化转氨酶(PAG)活性明显降低。缺血时间较短时酶活性下降是可逆的,但缺血90分钟后酶活性下降不可逆。这种退化是由局部缺血引起的视网膜功能性损伤。方法:在缺血前,将1穆尔生长因子或神经营养因子(胰岛素样生长因子-I(IGF-I)、胰岛素样生长因子-II(IGF-II)、脑源性神经营养因子(BDNF)、神经生长因子(NGF)为0.1摩尔/穆尔;碱性成纤维细胞生长因子(bFGF)为1摩尔/穆尔)注射到麻醉的Sprague道利大鼠左眼的玻璃体腔中。作为对照,将磷酸盐缓冲盐水注射到右眼。为了诱导缺血,我们在利姆布斯周围的球结膜切口后夹住左眼90分钟。再灌注后1天,用蒸馏水将大鼠视网膜匀浆并用于PAG测定。结果:缺血90 min再灌注1d后,视网膜PAG活性下降约80%,视网膜氨浓度升高约50%。IGF-II、BDNF和NGF对视网膜PAG活性有保护作用,而IGF-I、bFGF和稳定性bFGF的保护作用较弱。结论:BDNF、NGF和IGF-II对缺血再灌注大鼠视网膜PAG活性有明显的保护作用,而bFGF对缺血再灌注大鼠视网膜PAG活性的保护作用较弱。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeda, A.et al: "Induction of heparin-binding growth-associated molecule expression in reactive astrocytes following hippocampal neruonal injury." Neuroscience. Vol.68. 57-64 (1995)
Takeda, A.等人:“海马神经损伤后反应性星形胶质细胞中肝素结合生长相关分子表达的诱导。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A. Arakawa et al.: "Protection of activity decrease of phosphate-activated glutaminase by phospholipids in ischemic/reperfused rat retinas." Invest. Ophthalmol. Vis. Sci.Vol. 36. S127- (1995)
A. Arakawa 等人:“磷脂在缺血/再灌注大鼠视网膜中保护磷酸盐激活的谷氨酰胺酶活性降低。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeda, A et al: "Regional difference in induction of heme oxigenase-1 protein following rat transient for brain ischemia." Neuroscience Letter. Vol.205. 169-172 (1996)
Takeda, A 等人:“大鼠短暂脑缺血后血红素加氧酶 1 蛋白诱导的区域差异。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Endo, T. et al.: "A chinese hamster ovary cell mutant resistant to phosphatidylserine is defective in trasbilayer movement of cell surface phosphatidylserine." Exp. Cell Res.228. 341-346 (1996)
Endo, T. 等人:“对磷脂酰丝氨酸具有抗性的中国仓鼠卵巢细胞突变体在细胞表面磷脂酰丝氨酸的跨双层运动方面存在缺陷。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Endo,T.et al.: "A chinese hamster ovary cell mutant resistant to phosphatidylserine is defective in trasbilayer movement of cell surface phosphatidylserine" Exp.Cell Res.228. 341-346 (1996)
Endo,T.等人:“对磷脂酰丝氨酸具有抗性的中国仓鼠卵巢细胞突变体在细胞表面磷脂酰丝氨酸的跨双层运动中存在缺陷”Exp.Cell Res.228。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAMAI Makoto其他文献

TAMAI Makoto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAMAI Makoto', 18)}}的其他基金

Establishment of a method for restoring vision using light-gated ion channels and the promotion of optogenetics
光门离子通道恢复视力方法的建立及光遗传学的推广
  • 批准号:
    21200022
  • 财政年份:
    2009
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
Evaluation of protective and adverse effects of gene transferred IPE cell transplantation on degenerative retinal diseases
基因转移IPE细胞移植对退行性视网膜疾病的保护作用和不良作用评价
  • 批准号:
    15390524
  • 财政年份:
    2003
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
TREATMENT OF RETINAL DEGENERATIVE DISIESE BY TRANSPLANTATION OF GENE TRANSFERRED CELLS
基因转移细胞移植治疗视网膜退行性疾病
  • 批准号:
    12357010
  • 财政年份:
    2000
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration : basic and clinical research
自体虹膜色素上皮细胞移植治疗年龄相关性黄斑变性:基础和临床研究
  • 批准号:
    10307041
  • 财政年份:
    1998
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Basic research for clinical application of retina and optic nerve regeneration by transplantation
视网膜及视神经移植再生临床应用基础研究
  • 批准号:
    07307016
  • 财政年份:
    1995
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Regeneration of pigment cells and basic and clinical study for treatment of age-related macular degeneration
色素细胞再生及治疗年龄相关性黄斑变性的基础与临床研究
  • 批准号:
    06404061
  • 财政年份:
    1994
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Basic and clinical approach for analysis and treatment of the age related neovascular maculopathy
年龄相关性新生血管性黄斑病分析和治疗的基础和临床方法
  • 批准号:
    03404050
  • 财政年份:
    1991
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Molecular Biological Research for Hereditary Retinal Degeneration
遗传性视网膜变性的分子生物学研究
  • 批准号:
    01480413
  • 财政年份:
    1989
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Development of Image Processing System for Fundus Video-Angiography with Non-Stroboscopic Illumination
无频闪照明眼底视频血管造影图像处理系统的研制
  • 批准号:
    63870070
  • 财政年份:
    1988
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B).

相似海外基金

Elucidating and bypassing molecular mechanisms that suppress Muller glia-dependent regeneration of cones in two zebrafish models of chronic retinal damage
阐明和绕过抑制两种慢性视网膜损伤斑马鱼模型中穆勒胶质细胞依赖性视锥细胞再生的分子机制
  • 批准号:
    10567836
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage
间充质干细胞胞外囊泡治疗缺血性视网膜损伤
  • 批准号:
    10707009
  • 财政年份:
    2022
  • 资助金额:
    $ 11.26万
  • 项目类别:
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage
间充质干细胞胞外囊泡治疗缺血性视网膜损伤
  • 批准号:
    10843511
  • 财政年份:
    2022
  • 资助金额:
    $ 11.26万
  • 项目类别:
Formation of Retinyl-Opsins by Retinyl Formate as Molecular Shades Against Light-Induced Retinal Damage
视黄基甲酸形成视黄基视蛋白作为抗光诱导视网膜损伤的分子色调
  • 批准号:
    10390090
  • 财政年份:
    2022
  • 资助金额:
    $ 11.26万
  • 项目类别:
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage
间充质干细胞胞外囊泡治疗缺血性视网膜损伤
  • 批准号:
    10766045
  • 财政年份:
    2022
  • 资助金额:
    $ 11.26万
  • 项目类别:
Formation of Retinyl-Opsins by Retinyl Formate as Molecular Shades Against Light-Induced Retinal Damage
视黄基甲酸形成视黄基视蛋白作为抗光诱导视网膜损伤的分子色调
  • 批准号:
    10560484
  • 财政年份:
    2022
  • 资助金额:
    $ 11.26万
  • 项目类别:
Identification of intraocular proteins associated with retinal damage in macular edema secondary to retinal vein occlusion
视网膜静脉阻塞继发性黄斑水肿中与视网膜损伤相关的眼内蛋白的鉴定
  • 批准号:
    21K16870
  • 财政年份:
    2021
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Retinal damage induced by anti-CTLA4
抗CTLA4诱导的视网膜损伤
  • 批准号:
    19K18871
  • 财政年份:
    2019
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Retinal damage in a rat model of traumatic brain injury
大鼠脑外伤模型的视网膜损伤
  • 批准号:
    541337-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 11.26万
  • 项目类别:
    University Undergraduate Student Research Awards
Neuroprotective effect of PACAP against retinal damage in Glaucoma via immunomoduration
PACAP 通过免疫调节对青光眼视网膜损伤的神经保护作用
  • 批准号:
    24592681
  • 财政年份:
    2012
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了